|
Dr. Jeeri Reddy is an India-born American biologist who became an entrepreneur, developing new generation preventive and therapeutic vaccine for stroke. He has been an active leader in the field of biopharmaceutical industry, commercializing diagnostics and vaccines through JN-International Medical Corporation. He currently serves as Scientific Director and President of the Corporation that created the world's first serological rapid tests for Tuberculosis to facilitate acid-fast bacilli microscopy for the identification of smear-positive and negative cases. Prevention of mother-to-child transmission of HIV was achieved in South East Asia by the use of rapid tests developed by Reddy in 1999. Reddy through his Corporation donated $173,050 worth of Rapid Diagnostic Tests (RDTs) for malaria in Zambia〔RAPIDS Malaria Initiative: 2007 Final Report http://www.pepfar.gov〕 and actively participated in prevention of child deaths due to Malaria infections. Reddy was personally invited by the President George W. Bush and First Lady Laura Bush to the White House for Malaria Awareness Day sponsored by US President Malaria Initiative (PMI)〔http://www.pmi.gov/〕〔http://jn-vaccines.org/PMI.htm〕 on Wednesday, April 25, 2007. A notable inexpensive vaccine developed by Reddy is for Meningococcal meningitis for prevention of Meningitis disease outbreaks in sub-Saharan Africa,〔Method of producing Meningococcal meningitis vaccine for Neisseria meningitides serotypes A, C, Y, and W-135 http://www.jn-vaccines.org/US20080020428_1_JN_MENINGITIS_PATENT.pdf〕〔Jeeri R. Reddy and Thiombiano S. Rigobert. Infections à méningocoques Maladies infectious et Africa. West Africa. Med. Bull. 2007〕〔Jeeri R Reddy and Thiombiano S. Rigobert. Infections à méningocoques Maladies infectious et Africa. West Africa. Med. Bull. 2008〕〔Jeeri R. Reddy, Safety and Immunogenicity of Meningococcal Meningitis Quadrivalent (A,C,Y & W-135) Polysaccharide Vaccine "PHASE III MULTICENTER CLINICAL TRIAL IN SUB-SAHARAN AFRICA" 2008; West African Journal of Medicine (in press)〕 His main objective is to facilitate affordable biological medicines to the resource poor countries. His leadership on global health matters in Africa and South East Asia is encouraged by former President Bill Clinton through the Clinton Global Initiative.〔Clinton Global Initiative: Development and Production of Low-Cost Vaccines, 2006 https://www.clintonfoundation.org/clinton-global-initiative/commitments/development-and-production-low-cost-vaccines〕 Every year, Reddy with the help of a French physician Noel Kouame supply childhood vaccines to sub-Saharan Africa for vaccinating one million people for prevention of Bacterial Meningitis, Poliomyelitis, Diphtheria, Tetanus and Pertussis.〔A world in which all people at risk are protected against vaccine-preventable diseases http://who.int/en/ 〕 Reddy has been dedicated in prevention of infectious diseases by promoting public awareness and education about immunization for vaccine-preventable diseases in underdeveloped countries. The people who have helped him to become a businessman are his own classmates and friends from the school of Microbiology and Pharmaceutical Sciences. He has created jobs in Nebraska, USA, Africa and South East Asia through his company. Prior to forming the corporation by him in 1997, Reddy served as microbiologist, visiting professor and laboratory director at ICRISAT,〔Reddy, J R and Ahmed, K M and Varma, B K (1988) Bacterial wilt of chickpea caused by Xanthomonas campestris (Pam.) Dowson. International Chickpea Newsletter, 19. pp. 13-15. ISSN 0257-2508 http://oar.icrisat.org/2151/〕 Kansas State University and Central States Research Center, Oakland, Nebraska. Reddy is an inventor on five U.S. & International (PCT) Patents and publishes Journal articles of its research and technologies in the field of human Infectious Diseases and Neurological Disorders.〔〔REDDY Jeeri. Preventive and therapeutic vaccine for Stroke and Neurological Disorders http://www.wipo.int/pctdb/en/wo.jsp?WO=2008121146〕〔Seshu Kumar Gudlavalleti, Erika Nicole Crawford, Jeffery David Harder, and Jeeri Raghava Reddy |title=Quantification of each Serogroup Polysaccharide of Neisseria meningitidis in A/C/Y/W-135-DT Conjugate Vaccine by HighPerformance Anion-Exchange Chromatography-Pulsed Amperometric Detection Analysis http://www.ncbi.nlm.nih.gov/pubmed/?term=Jeeri+Raghava+Reddy〕 Reddy earned a doctoral degree in Microbiology and Infectious Diseases from the University of California at Berkeley and a Bachelor of Science degree and Master of Science degree in Biology and Microbiology from India.〔http://link.springer.com/article/10.1007%2FBF02602900〕 In June 1993, he was awarded by The Society of Phi Zeta of Kansas State University for his research findings of a vaccine against enteric, respiratory and reproductive disease-causing virus.〔The Society of Phi Zeta Sigma Chapter at Kansas State University: http://www.vet.k-state.edu/research/〕 Life sciences contributions at Research Gate:〔https://www.researchgate.net/profile/Jeeri_Reddy/contributions/〕 ==References== 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Jeeri R. Reddy」の詳細全文を読む スポンサード リンク
|